N-glycosylation of plant-produced recombinant proteins

Current Pharmaceutical Design

Volumn 19, Issue 31, 2013, Pages 5503-5512

  Bosch, Dirk ^a,b   Castilho, Alexandra ^c   Loos, Andreas ^c   Schots, Arjen ^a   Steinkellner, Herta ^c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Glyco engineering; Glycosylation; Plants; Recombinant proteins

Indexed keywords

OLIGOSACCHARIDE; RECOMBINANT PROTEIN;

CELL VACUOLE; ENDOPLASMIC RETICULUM; FUCOSYLATION; GLYCOSYLATION; HUMAN; MOLECULAR FARMING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; REVIEW; SECRETORY PATHWAY; TARGET CELL;

ANIMALS; GLYCOSYLATION; HUMANS; IMMUNE SYSTEM; METABOLIC ENGINEERING; MOLECULAR FARMING; PLANT PROTEINS; POLYSACCHARIDES; RECOMBINANT PROTEINS;

EID: 84879307489     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319310006     Document Type: Review

References (120)

1. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochimica et Biophysica Acta (BBA)-General Subjects 1999; 1473: 4-8.
2. Cummings RD. The repertoire of glycan determinants in the human glycome. Mol Biosyst 2009; 5: 1087-104.
3. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins. Annual Review of Immunology 2007; 25: 21-50.
4. Jefferis R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 2009; 8: 226-34.
5. Shinkawa T, Nakamura K, Yamane N, et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 2003; 278: 3466-73.
6. Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation. Science 2006; 313: 670-673.
7. Aggarwal S. What's fueling the biotech engine--2010 to 2011. Nat Biotechnol 2011; 29: 1083-9.
8. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG fc. Science 2008; 320: 373-6.
9. Hamadeh RM, Jarvis GA, Galili U, Mandrell RE, Zhou P, Griffiss JM. Human Natural Anti-Gal Igg Regulates Alternative Complement Pathway Activation on Bacterial Surfaces. J Clinical Investigation 1992; 89: 1223-35.
10. Chung CH, Mirakhur B, Chan E, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 2008; 358: 1109-17.
11. Zhao Y, Sato Y, Isaji T, et al. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J 2008; 275: 1939-48.
12. Jacobs PP, Callewaert N. N-glycosylation engineering of biopharmaceutical expression systems. Curr Mol Med 2009; 9: 774-800.
13. D'Aoust MA, Couture MM, Charland N, et al. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J 2010; 8: 607-19.
14. Sainsbury F, Thuenemann EC, Lomonossoff GP. pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol J 2009; 7: 682-93.
15. Pogue GP, Vojdani F, Palmer KE, et al. Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnol J 2010; 8: 638-54.
16. Hiatt A, Pauly M. Monoclonal antibodies from plants: a new speed record. Proc Natl Acad Sci USA 2006; 103: 14645-6.
17. Gleba Y, Giritch A. Vaccines, antibodies and pharmaceuticals 2012.
18. Walsh G. Biopharmaceutical benchmarks 2010. Nat Biotechnol 2010; 28: 917-24.
19. Fitchette-Laine AC, Gomord V, Cabanes M, et al. N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells. Plant Journal 1997; 12: 1411-7.
20. Strasser R, Bondili JS, Vavra U, et al. A unique beta1,3- galactosyltransferase is indispensable for the biosynthesis of N- glycans containing Lewis a structures in Arabidopsis thaliana. Plant Cell 2007; 19: 2278-92.
21. Betenbaugh MJ, Tomiya N, Narang S, Hsu JTA, Lee YC. Biosynthesis of human-type N-glycans in heterologous systems. Current Opinion in Structural Biology 2004; 14: 601-6.
22. Liebminger E, Veit C, Pabst M, et al. Beta-N- acetylhexosaminidases HEXO1 and HEXO3 are responsible for the formation of paucimannosidic N-glycans in Arabidopsis thaliana. J Biol Chem 2011; 286: 10793-802.
23. Strasser R, Stadlmann J, Schähs M, et al. Generation of glyco- engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 2008; 6: 392-402.
24. Castilho A, Bohorova N, Grass J, et al. Rapid high yield production of different glycoforms of Ebola virus monoclonal antibody. PLoS One 2011; 6: e26040.
25. Dirnberger D, Steinkellner H, Abdennebi L, Remy JJ, van de Wiel D. Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants. Eur J Biochem 2001; 268: 4570-9.
26. Strasser R, Bondili JS, Schoberer J, et al. Enzymatic properties and subcellular localization of Arabidopsis beta-N- acetylhexosaminidases. Plant Physiol 2007; 145: 5-16.
27. Weise A, Altmann F, Rodriguez-Franco M, et al. High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Delta-fuc-t Delta-xyl-t mutant. Plant Biotechnol J 2007; 5: 389-401.
28. Castilho A, Gattinger P, Grass J, et al. N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 2011; 21: 813-23.
29. Loos A, Steinkellner H. IgG-Fc glycoengineering in non- mammalian expression hosts. Arch Biochem Biophys 2012.
30. Nagels B, Weterings K, Callewaert N, Van Damme EJM. Production of Plant Made Pharmaceuticals: From Plant Host to Functional Protein. Critical Reviews in Plant Sciences 2012; 31: 148-80.
31. Schouten A, Roosien J, vanEngelen FA, et al. The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Molecular Biology 1996; 30: 781-93.
32. Sack M, Paetz A, Kunert R, Bomble M, Hesse F, Stiegler G, Fischer R, Katinger H, Stoeger E, Rademacher T. Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures. FASEB J 2007; 21: 1655-64.
33. Rademacher T, Sack M, Arcalis E, et al. Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J 2008; 6: 189-201.
34. Petruccelli S, Otegui MS, Lareu F, et al. A KDEL-tagged monoclonal antibody is efficiently retained in the endoplasmic reticulum in leaves, but is both partially secreted and sorted to protein storage vacuoles in seeds. Plant Biotechnology Journal 2006; 4: 511-27.
35. Fiedler U, Phillips J, Artsaenko O, Conrad U. Optimization of scFv antibody production in transgenic plants. Immunotechnology 1997; 3: 205-16.
36. Sainsbury F, Lomonossoff GP. Extremely High-Level and Rapid Transient Protein Production in Plants without the Use of Viral Replication. Plant Physiol 2008; 148: 1212-8.
37. Ko K, Tekoah Y, Rudd PM, et al. Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci USA 2003; 100: 8013-8.
38. Floss DM, Sack M, Stadlmann J, et al. Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants. Plant Biotechnol J 2008; 6: 379-91.
39. Brodzik R, Glogowska M, Bandurska K, et al. Plant-derived anti- Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells. Proc Natl Acad Sci USA 2006; 103: 8804-9.
40. Lee SJ, Evers S, Roeder D, et al. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 2002; 295: 1898-1901.
41. Van Droogenbroeck B, Cao J, Stadlmann J, et al. Aberrant localization and underglycosylation of highly accumulating single- chain Fv-Fc antibodies in transgenic Arabidopsis seeds. Proc Natl Acad Sci USA 2007; 104: 1430-5.
42. Loos A, Van Droogenbroeck B, Hillmer S, et al. Expression of antibody fragments with a controlled N-glycosylation pattern and induction of endoplasmic reticulum-derived vesicles in seeds of Arabidopsis. Plant Physiol 2011; 155: 2036-48.
43. Ibl V, Stoger E. The formation, function and fate of protein storage compartments in seeds. Protoplasma 2012; 249: 379-92.
44. Conley AJ, Joensuu JJ, Richman A, Menassa R. Protein body- inducing fusions for high-level production and purification of recombinant proteins in plants. Plant Biotechnol J 2011; 9: 419-33.
45. Loos A, Van Droogenbroeck B, Hillmer S, et al. Production of monoclonal antibodies with a controlled N-glycosylation pattern in seeds of Arabidopsis thaliana. Plant Biotechnol J 2011; 9: 179-92.
46. Arcalis E, Marcel S, Altmann F, et al. Unexpected deposition patterns of recombinant proteins in post-endoplasmic reticulum compartments of wheat endosperm. Plant Physiol 2004; 136: 3457-66.
47. He X, Haselhorst T, von Itzstein M, Kolarich D, Packer NH, Kermode AR. Influence of an ER-retention signal on the Nglycosylation of recombinant human alpha-L-iduronidase generated in seeds of Arabidopsis. Plant Mol Biol 2012; 79: 157-69.
48. Arcalis E, Stadlmann J, Marcel S, et al. The changing fate of a secretory glycoprotein in developing maize endosperm. Plant Physiol 2010; 153: 693-702.
49. Ramessar K, Rademacher T, Sack M, et al. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci USA 2008; 105: 3727-32.
50. Paris N, Stanley CM, Jones RL, Rogers JC. Plant cells contain two functionally distinct vacuolar compartments. Cell 1996; 85: 563-72.
51. Foresti O, Denecke J. Intermediate organelles of the plant secretory pathway: Identity and function. Traffic 2008; 9: 1599-612.
52. Bottanelli F, Foresti O, Hanton S, Denecke J. Vacuolar transport in tobacco leaf epidermis cells involves a single route for soluble cargo and multiple routes for membrane cargo. Plant Cell 2011; 23: 3007-25.
53. Robinson DG, Oliviusson P, Hinz G. Protein sorting to the storage vacuoles of plants: a critical appraisal. Traffic 2005; 6: 615-25.
54. Vitale A, Hinz G. Sorting of proteins to storage vacuoles: how many mechanisms? Trends Plant Sci 2005; 10: 316-23.
55. Jolliffe NA, Craddock CP, Frigerio L. Pathways for protein transport to seed storage vacuoles. Biochemical Society Transactions 2005; 33: 1016-8.
56. Jorgensen M, Stensballe A, Welinder KG. Extensive post- translational processing of potato tuber storage proteins and vacuolar targeting. FEBS J 2011; 278: 4070-87.
57. Masclaux FG, Galaud JP, Pont-Lezica R. The riddle of the plant vacuolar sorting receptors. Protoplasma 2005; 226: 103-8.
58. Nicholson L, Gonzalez-Melendi P, van Dolleweerd C, et al. A recombinant multimeric immunoglobulin expressed in rice shows assembly-dependent subcellular localization in endosperm cells. Plant Biotechnol J 2005; 3: 115-27.
59. Reggi S, Marchetti S, Patti T, et al. Recombinant human acid- glucosidase stored in tobacco seed is stable, active and taken up by human fibroblasts. Plant Molecular Biology 2005; 57: 101-113.
60. Wright KE, Prior F, Sardana R, et al. Sorting of glycoprotein B from human cytomegalovirus to protein storage vesicles in seeds of transgenic tobacco. Transgenic Res 2001; 10: 177-81.
61. Sonnewald U, Brauer M, von Schaewen A, Stitt M, Willmitzer L. Transgenic tobacco plants expressing yeast-derived invertase in either the cytosol, vacuole or apoplast: a powerful tool for studying sucrose metabolism and sink/source interactions. Plant J 1991; 1: 95-106.
62. Neuhaus JM, Sticher L, Meins F, Jr., Boller T. A short C-terminal sequence is necessary and sufficient for the targeting of chitinases to the plant vacuole. Proc Natl Acad Sci USA 1991; 88: 10362-6.
63. Frigerio L, de Virgilio M, Prada A, Faoro F, Vitale A. Sorting of phaseolin to the vacuole is saturable and requires a short C-terminal peptide. Plant Cell 1998; 10: 1031-42.
64. Shaaltiel Y, Bartfeld D, Hashmueli S, et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnol J 2007; 5: 579-90.
65. Cheung SC, Sun SS, Chan JC, Tong PC. Expression and subcellular targeting of human insulin-like growth factor binding protein-3 in transgenic tobacco plants. Transgenic Res 2009; 18: 943-51.
66. Lau OS, Ng DW, Chan WW, Chang SP, Sun SS. Production of the 42-kDa fragment of Plasmodium falciparum merozoite surface protein 1, a leading malaria vaccine antigen, in Arabidopsis thaliana seeds. Plant Biotechnol J 2010; 8: 994-1004.
67. Lerouge P, Cabanes-Macheteau M, Rayon C, et al. N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol Biol 1998; 38: 31-48.
68. Almon-Brill E, Chertkoff R, Golembo M, et al. 'Novel ERT for Gaucher disease; Completion of clinical program required for marketing approval with plant cell expressed recombinant glucocerebrosidase-taliglucerase alfa'. Conference: Plant Based Vaccines and Antibodies 2011.
69. van Ree R. Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. International Archives of Allergy and Immunology 2002; 129: 189-197.
70. Bublin M, Radauer C, Wilson IBH, Kraft D, Scheiner O, Breiteneder H, Hoffmann-Sommergruber K. Cross-reactive Nglycans of Api g 5, a high molecular weight glycoprotein allergen from celery, are required for immunoglobulin E binding and activation of effector cells from allergic patients. Faseb Journal 2003; 17: 1697
71. Foetisch K, Westphal S, Lauer I, et al. Biological activity of IgE specific for cross-reactive carbohydrate determinants. Journal of Allergy and Clinical Immunology 2003; 111: 889-96.
72. Mari A. IgE to cross-reactive carbohydrate determinants: Analysis of the distribution and appraisal of the in vivo and in vitro reactivity. International Archives of Allergy and Immunology 2002; 129: 286-95.
73. van Ree R. Clinical importance of cross-reactivity in food allergy. Curr Opin Allergy Clin Immunol 2004; 4: 235-40.
74. Bardor M, Faveeuw C, Fitchette AC, et al. Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)- fucose and core xylose. Glycobiology 2003; 13: 427-434.
75. Jin C, Altmann F, Strasser R, et al. A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology 2008; 18: 235-41.
76. Faye L, Chrispeels MJ. Common antigenic determinants in the glycoproteins of plants, molluscs and insects. Glycoconjugate Journal 1988; 5: 245-56.
77. Chargelegue D, Vine ND, van Dolleweerd CJ, Drake PM, Ma JK. A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Transgenic Res 2000; 9: 187-94.
78. Mari A, Ooievaar-de Heer P, Scala E, et al. Evaluation by double- blind placebo-controlled oral challenge of the clinical relevance of IgE antibodies against plant glycans. Allergy 2008; 63: 891-6.
79. Ma JK, Hikmat BY, Wycoff K, et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 1998; 4: 601-6.
80. Schahs M, Strasser R, Stadlmann J, Kunert R, Rademacher T, Steinkellner H. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol J 2007; 5: 657-63.
81. Strasser R, Altmann F, Mach L, Glössl J, Steinkellner H. Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose. FEBS Lett 2004; 561: 132-6.
82. Cox KM, Sterling JD, Regan JT, et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 2006; 24: 1591-7.
83. Koprivova A, Stemmer C, Altmann F, et al. Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol J 2004; 2: 517-23.
84. Sourrouille C, Marquet-Blouin E, D'Aoust MA, et al. Down- regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol J 2008; 6: 702-21.
85. Shin YJ, Chong YJ, Yang MS, Kwon TH. Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure. Plant Biotechnol J 2011; 9: 1109-19.
86. Zeitlin L, Pettitt J, Scully C, et al. Enhanced potency of a fucose- free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc Natl Acad Sci USA 2011; 108: 20690-4.
87. Forthal DN, Gach JS, Landucci G, et al. Fc-glycosylation influences Fc receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J Immunol 2010; 185: 6876-82.
88. Parsons J, Altmann F, Arrenberg CK, et al. Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants. Plant Biotechnol J 2012.
89. Jansen PL, De Bruijne J. Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C. Expert Opin Investig Drugs 2012; 21: 111-8.
90. Taniguchi N, Korekane H. Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics. BMB Rep 2011; 44: 772-81.
91. Ferrara C, Stuart F, Sondermann P, Brunker P, Umana P. The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J Biol Chem 2006; 281: 5032-6.
92. Okada T, Ihara H, Ito R, et al. N-Glycosylation engineering of lepidopteran insect cells by the introduction of the beta1,4-N- acetylglucosaminyltransferase III gene. Glycobiology 2010; 20: 1147-59.
93. Rouwendal GJ, Wuhrer M, Florack DE, et al. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. Glycobiology 2007; 17: 334-44.
94. Frey AD, Karg SR, Kallio PT. Expression of rat beta(1,4)-N- acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation. Plant Biotechnol J 2009; 7: 33-48.
95. Karg SR, Frey AD, Kallio PT. Reduction of N-linked xylose and fucose by expression of rat beta1,4-N-acetylglucosaminyl- transferase III in tobacco BY-2 cells depends on Golgi enzyme localization domain and genetic elements used for expression. J Biotechnol 2010; 146: 54-65.
96. Nagels B, Van Damme EJ, Pabst M, Callewaert N, Weterings K. Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. Plant Physiol 2011; 155: 1103-12.
97. Palacpac NQ, Yoshida S, Sakai H, et al. Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N- linked glycosylation patterns. Proc Natl Acad Sci USA 1999; 96: 4692-7.
98. Misaki R, Kimura Y, Palacpac NQ, Yoshida S, Fujiyama K, Seki T. Plant cultured cells expressing human Î 1,4-galactosyltransferase secrete glycoproteins with galactose-extended N-linked glycans. Glycobiology 2003; 13: 199-205.
99. Bakker H, Bardor M, Molthoff JW, et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci USA 2001; 98: 2899-904.
100. Bakker H, Rouwendal GJ, Karnoup AS, et al. An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyl- transferase is essentially devoid of plant carbohydrate epitopes. Proc Natl Acad Sci USA 2006; 103: 7577-82.
101. Fujiyama K, Furukawa A, Katsura A, Misaki R, Omasa T, Seki T. Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human beta(1,4)-galactosyltransferase. Biochem Biophys Res Commun 2007; 358: 85-91.
102. Strasser R, Castilho A, Stadlmann J, et al. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J Biol Chem 2009; 284: 20479-85.
103. Wang J, Zhang Y, Wei J, et al. Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response. Immunology 2007; 121: 174-82.
104. Rouwendal GJ, Florack DE, Hesselink T, Cordewener JH, Helsper JP, Bosch D. Synthesis of Lewis X epitopes on plant N-glycans. Carbohydr Res 2009; 344: 1487-93.
105. Zeleny R, Kolarich D, Strasser R, Altmann F. Sialic acid concentrations in plants are in the range of inadvertent contamination. Planta 2006; 224: 222-7.
106. Seveno M, Bardor M, Paccalet T, Gomord V, Lerouge P, Faye L. Glycoprotein sialylation in plants? Nat Biotechnol 2004; 22: 1351-2; author reply 1352-3.
107. Shah MM, Fujiyama K, Flynn CR, Joshi L. Sialylated endogenous glycoconjugates in plant cells. Nat Biotechnol 2003; 21: 1470-1.
108. Bakker H, Routier F, Ashikov A, Neumann D, Bosch D, Gerardy-Schahn R. A CMP-sialic acid transporter cloned from Arabidopsis thaliana. Carbohydr Res 2008; 343: 2148-52.
109. Wee EG, Sherrier DJ, Prime TA, Dupree P. Targeting of active sialyltransferase to the plant Golgi apparatus. Plant Cell 1998; 10: 1759-68.
110. Misaki R, Fujiyama K, Seki T. Expression of human CMP-N- acetylneuraminic acid synthetase and CMP-sialic acid transporter in tobacco suspension-cultured cell. Biochem Biophys Res Commun 2006; 339: 1184-9.
111. Castilho A, Pabst M, Leonard R, et al. Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis. Plant Physiol 2008; 147: 331-9.
112. Castilho A, Strasser R, Stadlmann J, et al. In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 2010; 285: 15923-30.
113. Jez J, Castilho A, Grass J, Vorauer-Uhl K, Sterovsky T, Altmann F, Steinkellner H. Expression of functionally active sialyated human erythropoietin in plants. Biotechnol J, 2013; doi: 10.1000/biot.201200363.
114. Nagels B, Van Damme EJ, Callewaert N, et al. Biologically active, magnICON(®)-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. J Biotechnol 2012.
115. Castilho A, Neuman L, Gattinger P, Strasser R, Vorauer-Uhl K, Sterovsky T, Altman F, Steinkellner H. Generation of Biologicaly Active Multi-Sialylated Recombinant Human EPOFc in Plants. PloS One 2013; 8: e54836. Doi: 10.1371/journal.pone.0054836.
116. Morgan WT, Watkins WM. Genetic and biochemical aspects of human blood-group A-, B-, H-, Le-a-and Le-b-specificity. Br Med Bull 1969; 25: 30-4.
117. Berends E, Scholtmeijer K, Wosten HA, Bosch D, Lugones LG. The use of mushroom-forming fungi for the production of N- glycosylated therapeutic proteins. Trends Microbiol 2009; 17: 439-43.
118. Bosch D, Schots A. Plant glycans: friend or foe in vaccine development? Expert Rev Vaccines 2010; 9: 835-42.
119. Singh SK, Stephani J, Schaefer M, et al. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Mol Immunol 2009; 47: 164-74.
120. Shreffler WG, Castro RR, Kucuk ZY, et al. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol 2006; 177: 3677-85.